Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.

Clinical colorectal cancer

Volumn 5, Issue 2, 2005, Pages 124-131

  Zhang, W ^a   Stoehlmacher, Jan ^a   Park, David J ^a   Yang, Dongyun ^a   Borchard, Erin ^a   Gil, J ^a   Tsao Wei, Denice D ^a   Yun, Jim ^a   Gordon, Michael ^a   Press, Oliver A ^a   Rhodes, Katrin ^a   Groshen, Susan ^a   Lenz, Heinz Josef ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; FLUOROURACIL; FOLINIC ACID; INTERLEUKIN 8; OXALIPLATIN; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROTO ONCOGENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; GENES, ERBB-1; HUMANS; INTERLEUKIN-8; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RISK; SURVIVAL RATE;

EID: 33644841038     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.3816/CCC.2005.n.025     Document Type: Article

References (0)